HEXO Corp (HEXO)

[JohnCM]

Then there’s Hexo Corp.

HEXO, a licensed producer and distributor of medical marijuana based in Gatineau in western Quebec. The company was founded in 2013 and made its first medical-cannabis sales in May 2015, according to its website.

Like many others, Hexo is planning to expand into the recreational market and is working to grow production capacity. For now, it has more than 310,000 square feet of capacity and is adding another 1 million square feet, which is expected to be ready by year-end. It will serve the adult recreational market through its Hexo brand and continue its medical offering through its Hydropothecary brand.

In its third fiscal quarter, which ended April 30, the company sold 134.3 kilograms of cannabis, down from 137.1 kilograms in the same period a year ago. The company sold the weed at an average of C$9.24 per gram (US$7.12), up from C$8.62 a year ago. Its weighted average cash cost of dried inventory was 88 cents, down from C$2.06 a year ago. The company says that metric includes direct costs associated with the growing, harvesting and processing of inventory sold such as labor, utilities, fertilizer, curing, milling and testing.

The six analysts who cover the stock all rate it as a buy, with a mean price target of C$9.25, about 18% above its current trading level.